IMTYTIM Trademark

Trademark Overview


On Tuesday, August 18, 2020, a trademark application was filed for IMTYTIM with the United States Patent and Trademark Office. The USPTO has given the IMTYTIM trademark a serial number of 79295502. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, June 4, 2024. This trademark is owned by NOVARTIS AG. The IMTYTIM trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
imtytim

General Information


Serial Number79295502
Word MarkIMTYTIM
Filing DateTuesday, August 18, 2020
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, June 4, 2024
Registration Number6367027
Registration DateTuesday, June 1, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 16, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, June 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, October 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 8, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 21, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, October 23, 2020ASSIGNED TO EXAMINER
Tuesday, October 27, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, October 28, 2020NON-FINAL ACTION WRITTEN
Monday, November 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 29, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 2, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, November 30, 2020NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, December 2, 2020NON-FINAL ACTION WRITTEN
Thursday, December 3, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 16, 2020REFUSAL PROCESSED BY MPU
Wednesday, December 16, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 4, 2021REFUSAL PROCESSED BY IB
Friday, February 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, March 15, 2021NOTIFICATION PROCESSED BY IB
Tuesday, June 1, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, September 24, 2021FINAL DISPOSITION NOTICE SENT TO IB
Sunday, June 23, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, June 23, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Monday, October 25, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 1, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, September 24, 2021FINAL DISPOSITION PROCESSED